losartan-potassium and Genital-Diseases--Female

losartan-potassium has been researched along with Genital-Diseases--Female* in 3 studies

Reviews

1 review(s) available for losartan-potassium and Genital-Diseases--Female

Article	Year
Polycythemia: diagnosis, pathophysiology and therapy. II. Canadian Medical Association journal, 1969, Feb-15, Volume: 100, Issue:7 Topics: Animals; Central Nervous System Diseases; Erythropoiesis; Erythropoietin; Female; Genes, Regulator; Genital Diseases, Female; Hemodynamics; Humans; Hypertension; Hypoxia; Kidney; Kidney Diseases; Liver Diseases; Male; Polycythemia; Polycythemia Vera; Rats	1969

Trials

1 trial(s) available for losartan-potassium and Genital-Diseases--Female

Article	Year
[Human recombinant erythropoietin in the treatment of anemia in obstetric-gynecologic patients. Evaluation of such treatment as an alternative to blood transfusion]. Minerva ginecologica, 1996, Volume: 48, Issue:3 The authors introduce the subject with physiological comments regarding the ability of r-HuEP to stimulate erythropoietic bone marrow, underlining the need for other molecules to backup the therapy (vitamin B12, folic acid and iron). Subsequently, and in the light of this introduction, they outline the indications for r-HuEPO treatment in specialist fields and the relative contraindications. They then report the results obtained in a group of 24 patients with the relevant indications receiving subcutaneous treatment on alterate days with r-HuEPO in fials of 4000 IU/ml. Basal hemoglobin levels were 6-8 g and treatment was continued until levels of around 10-11 g were reached; tolerance was good in both gynecological and obstetric patients. Topics: Adult; Anemia; Blood Transfusion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythropoietin; Female; Ferrous Compounds; Folic Acid; Genital Diseases, Female; Humans; Pregnancy; Puerperal Disorders; Vitamin B 12	1996

Article

Year

[Human recombinant erythropoietin in the treatment of anemia in obstetric-gynecologic patients. Evaluation of such treatment as an alternative to blood transfusion].

Minerva ginecologica, 1996, Volume: 48, Issue:3

The authors introduce the subject with physiological comments regarding the ability of r-HuEP to stimulate erythropoietic bone marrow, underlining the need for other molecules to backup the therapy (vitamin B12, folic acid and iron). Subsequently, and in the light of this introduction, they outline the indications for r-HuEPO treatment in specialist fields and the relative contraindications. They then report the results obtained in a group of 24 patients with the relevant indications receiving subcutaneous treatment on alterate days with r-HuEPO in fials of 4000 IU/ml. Basal hemoglobin levels were 6-8 g and treatment was continued until levels of around 10-11 g were reached; tolerance was good in both gynecological and obstetric patients.

Topics: Adult; Anemia; Blood Transfusion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythropoietin; Female; Ferrous Compounds; Folic Acid; Genital Diseases, Female; Humans; Pregnancy; Puerperal Disorders; Vitamin B 12

1996

Other Studies

1 other study(ies) available for losartan-potassium and Genital-Diseases--Female

Article	Year
[The laboratory evidences of chronic disease impact on the development of anemia under female reproductive system pathology]. Klinicheskaia laboratornaia diagnostika, 2011, Issue:7 The study sample included 170 patients with gynecological diseases, 5 patients with persistent anemia due to systematic blood disorder, 14 healthy patients. The decrease of hemoglobin level lower than 110 g/l is established in 25.7% gynecologic patients and most frequently in those with hysteromyoma. The study revealed that anemia developed due to the female reproductive system disorders and independently of clinically marked loss of blood is an. The biologic characteristic of anemia is the decrease of erythrocytes production under certain diseases against the background of inadequate production of endogenic erythropoietin. The effectiveness of treatment of iron-deficiency anemia is less under decrease of amount of erythrokaryocytes in bone marrow. Topics: Adult; Aged; Anemia, Iron-Deficiency; Bone Marrow; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Genital Diseases, Female; Hemoglobins; Humans; Leiomyoma; Middle Aged	2011

Article

Year

[The laboratory evidences of chronic disease impact on the development of anemia under female reproductive system pathology].

Klinicheskaia laboratornaia diagnostika, 2011, Issue:7

The study sample included 170 patients with gynecological diseases, 5 patients with persistent anemia due to systematic blood disorder, 14 healthy patients. The decrease of hemoglobin level lower than 110 g/l is established in 25.7% gynecologic patients and most frequently in those with hysteromyoma. The study revealed that anemia developed due to the female reproductive system disorders and independently of clinically marked loss of blood is an. The biologic characteristic of anemia is the decrease of erythrocytes production under certain diseases against the background of inadequate production of endogenic erythropoietin. The effectiveness of treatment of iron-deficiency anemia is less under decrease of amount of erythrokaryocytes in bone marrow.

Topics: Adult; Aged; Anemia, Iron-Deficiency; Bone Marrow; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Genital Diseases, Female; Hemoglobins; Humans; Leiomyoma; Middle Aged

2011